2014
DOI: 10.1007/s00381-014-2591-4
|View full text |Cite
|
Sign up to set email alerts
|

Understanding the reasons for delayed referral for intrathecal baclofen therapy in pediatric patients with severe spasticity

Abstract: Despite the limitations of this subjective retrospective analysis of outcomes and delay in referral, the opinions of the parents and caregivers should be considered. Earlier referral for ITB therapy may better treat severe spasticity in pediatric patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
7
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 21 publications
1
7
0
Order By: Relevance
“…Larger studies on ITB treatment in children with CP may lead to further development of treatment standards and recommendations, based on sound evidence, 14 and serve as a basis for informed decisions about ITB, and as an argument for ITB in countries and regions that do not yet offer this treatment to children with CP. Such studies may also reduce perceived delay in treatment, discussed recently by Berman et al 25 We conclude that there are significant differences in access to ITB treatment for children with CP across Europe, which illustrate the inequalities in health care that these children face. Furthermore, the frequency of ITB treatment differs between boys and girls.…”
Section: Discussionsupporting
confidence: 55%
“…Larger studies on ITB treatment in children with CP may lead to further development of treatment standards and recommendations, based on sound evidence, 14 and serve as a basis for informed decisions about ITB, and as an argument for ITB in countries and regions that do not yet offer this treatment to children with CP. Such studies may also reduce perceived delay in treatment, discussed recently by Berman et al 25 We conclude that there are significant differences in access to ITB treatment for children with CP across Europe, which illustrate the inequalities in health care that these children face. Furthermore, the frequency of ITB treatment differs between boys and girls.…”
Section: Discussionsupporting
confidence: 55%
“…There are musculoskeletal consequences in delayed or nonintervention, including contracture, ankylosis, and skin breakdown . These detrimental processes could potentially overwhelm any potential benefits of ITB therapy.…”
Section: Timing Of Interventionmentioning
confidence: 99%
“…Intrathecal baclofen for patients with CP safely and effectively reduces spasticity, pain, and dystonia; in addition, it confers superior functional abilities and results in improved management by caregivers. 1,2,[9][10][11][12]21,25,33,36,43,48 However, many patients who require baclofen present with concomitant scoliosis; their spinal torsion, or fusion mass and instrumentation, further increases the challenge of device implantation. 4,6,20,24,27,34,35,41,42 Moreover, procedural complications decrease the cost-benefit ratio of intervention.…”
Section: Discussionmentioning
confidence: 99%
“…11,27,28,43 Significant potential postoperative complications include CSF leakage, wound dehiscence, catheter disconnection or dislodgment, and surgical site infection-the latter of which may lead to meningitis and necessitate explantation. 2,9,11,17,20,22,24,27,34,36 Difficulty entering the spinal canal has been reported in patients with scoliosis who have had surgical correction and lumbar fusions, specifically iatrogenic damage to the catheter, incidental durotomies, CSF leakage, and failure of access. 29,32,44 Several strategies have been described to facilitate IT catheterization in this setting.…”
Section: Discussionmentioning
confidence: 99%